Kagey-Sobotka A - Search Results

1

Responses to ragweed-pollen nasal challenge before and after immunotherapy.

Creticos PS, Marsh DG, Proud D, Kagey-Sobotka A, Adkinson NF Jr, Friedhoff L, Naclerio RM, Lichtenstein LM, Norman PS. Creticos PS, et al. J Allergy Clin Immunol. 1989 Aug;84(2):197-205. doi: 10.1016/0091-6749(89)90325-4. J Allergy Clin Immunol. 1989. PMID: 2668381

2

The effect of azelastine on the early allergic response.

Shin MH, Baroody F, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Shin MH, et al. Clin Exp Allergy. 1992 Feb;22(2):289-95. doi: 10.1111/j.1365-2222.1992.tb03085.x. Clin Exp Allergy. 1992. PMID: 1349259 Clinical Trial.

3

Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils.

Iliopoulos O, Baroody FM, Naclerio RM, Bochner BS, Kagey-Sobotka A, Lichtenstein LM. Iliopoulos O, et al. J Immunol. 1992 Apr 1;148(7):2223-8. J Immunol. 1992. PMID: 1372025

4

Budesonide in grass pollen rhinitis.

Norman PS, Creticos PS, Tobey R, Proud DG, Kagey-Sobotka A, Meyers DA, Persson T. Norman PS, et al. Ann Allergy. 1992 Oct;69(4):309-16. Ann Allergy. 1992. PMID: 1416266 Clinical Trial.

5

Local application of atropine attenuates the upper airway reaction to cold, dry air.

Cruz AA, Togias AG, Lichtenstein LM, Kagey-Sobotka A, Proud D, Naclerio RM. Cruz AA, et al. Am Rev Respir Dis. 1992 Aug;146(2):340-6. doi: 10.1164/ajrccm/146.2.340. Am Rev Respir Dis. 1992. PMID: 1489122 Clinical Trial.

6

Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine.

Baroody FM, Cruz AA, Lichtenstein LM, Kagey-Sobotka A, Proud D, Naclerio RM. Baroody FM, et al. J Allergy Clin Immunol. 1992 Sep;90(3 Pt 1):373-6. doi: 10.1016/s0091-6749(05)80017-x. J Allergy Clin Immunol. 1992. PMID: 1527319 Free article. Clinical Trial.

7

Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapy.

Golden DB, Lawrence ID, Hamilton RH, Kagey-Sobotka A, Valentine MD, Lichtenstein LM. Golden DB, et al. J Allergy Clin Immunol. 1992 Sep;90(3 Pt 1):386-93. doi: 10.1016/s0091-6749(05)80019-3. J Allergy Clin Immunol. 1992. PMID: 1527321 Free article.

8

Evaluation of a bedtime dose of a combination antihistamine/analgesic/decongestant product on antigen challenge the next morning.

Majchel AM, Proud D, Kagey-Sobotka A, Witek TJ Jr, Lichtenstein LM, Naclerio RM. Majchel AM, et al. Laryngoscope. 1992 Mar;102(3):330-4. doi: 10.1288/00005537-199203000-00016. Laryngoscope. 1992. PMID: 1545660 Clinical Trial.

9

Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen.

Proud D, Sweet J, Stein P, Settipane RA, Kagey-Sobotka A, Friedlaender MH, Lichtenstein LM. Proud D, et al. J Allergy Clin Immunol. 1990 May;85(5):896-905. doi: 10.1016/0091-6749(90)90075-f. J Allergy Clin Immunol. 1990. PMID: 1692049

10

Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.

Naclerio RM, Kagey-Sobotka A, Lichtenstein LM, Freidhoff L, Proud D. Naclerio RM, et al. Am Rev Respir Dis. 1990 Jul;142(1):167-71. doi: 10.1164/ajrccm/142.1.167. Am Rev Respir Dis. 1990. PMID: 1695070 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

215 results

Search Page